What is the management for a patient presenting with hematemesis and shivering?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hematemesis with Shivering

A patient presenting with hematemesis and shivering requires immediate resuscitation with large-bore IV access, fluid administration targeting systolic blood pressure of 80-100 mmHg until bleeding is controlled, urgent endoscopy within 24 hours, and treatment of the shivering with meperidine (12.5-50 mg) which has potent anti-shivering properties while simultaneously addressing the underlying bleeding source. 1, 2

Immediate Stabilization and Assessment

Hemodynamic Resuscitation:

  • Secure large-bore intravenous access (ideally 8-Fr central access in adults) immediately to allow for rapid fluid resuscitation 1
  • Administer high FiO2 to ensure adequate oxygenation 1
  • Target systolic blood pressure of 80-100 mmHg until major bleeding has been controlled 2, 1
  • Actively warm the patient and all transfused fluids to prevent hypothermia, which can worsen coagulopathy 1

Critical Laboratory Studies:

  • Obtain baseline complete blood count, prothrombin time (PT), activated partial thromboplastin time (aPTT), and Clauss fibrinogen 1
  • Measure serum lactate and base deficit to estimate and monitor the extent of bleeding and shock 1
  • Do not rely on single hemoglobin/hematocrit measurements as isolated markers for bleeding severity, as they may not reflect acute blood loss 1, 2

Management of Shivering

Pharmacologic Anti-Shivering Therapy:

  • Meperidine 12.5-50 mg is the preferred agent due to its potent anti-shivering properties 2
  • Be aware that meperidine has an active metabolite associated with neurotoxicity and decreases seizure threshold 2
  • Alternative agents include magnesium sulfate (2-4 g bolus, then 1 g/h every 2-4 hours) as an adjunct 2
  • Consider ondansetron 4-8 mg every 4-8 hours in a preventative manner, though effects are limited 2

Non-Pharmacologic Measures:

  • Initiate surface counterwarming immediately 2
  • Consider acetaminophen as an adjunct 2

Blood Product Administration

Transfusion Strategy:

  • Transfuse packed red blood cells to maintain hemoglobin above 7 g/dL in most patients 1
  • Consider a higher transfusion threshold of 9 g/dL in patients with massive bleeding, significant cardiovascular comorbidities, or when therapeutic interventions may be delayed 1
  • For massive hemorrhage, administer warmed blood and blood components 1
  • Use blood products in order of availability: O-type blood, group-specific blood, then cross-matched blood 1

Urgent Endoscopic Management

Timing and Approach:

  • Perform urgent endoscopic assessment within 24 hours of presentation after initial stabilization 1, 3
  • The success rate is highest if endoscopy is performed within the first 36 hours of the onset of bleeding 4
  • Insert a nasogastric tube to protect the airway, decompress the stomach, and assess ongoing bleeding 1

Endoscopic Interventions:

  • Implement appropriate endoscopic hemostatic interventions based on findings (injection, thermal, or mechanical methods) 1, 3
  • Epinephrine injection should always be used in conjunction with another method to increase success of achieving hemostasis 3

Pharmacologic Adjuncts:

  • Administer intravenous proton pump inhibitors in the acute setting to decrease the probability of high-risk stigmata seen during endoscopy 3
  • Consider pro-kinetic agents 30 minutes to one hour before endoscopy to aid in diagnosis 3

When Endoscopy Fails or Is Unavailable

Alternative Interventions:

  • Consider interventional radiology angiographic embolization techniques when endoscopy is unsuccessful 1
  • For massive, life-threatening bleeding, surgical intervention may be necessary 1

Critical Pitfalls to Avoid

  • Avoid delays between presentation and intervention for patients requiring urgent bleeding control 1, 2
  • Do not rely solely on blood pressure as an indicator of blood loss, as some patients compensate well despite significant hemorrhage 1
  • Recognize that 65% of hemorrhages subside spontaneously, but 25% bleed recurrently and 75% of renewed bleeding occurs within two days after the initial hemorrhage 4
  • Be aware that bloody hematemesis is not necessarily more severe than coffee-grounds emesis, though it is associated with modestly higher rates of hemostatic intervention and rebleeding 5

Disposition

  • Admit the patient to a critical care area for monitoring after initial stabilization 1
  • Begin standard venous thromboprophylaxis as soon as bleeding is controlled 1
  • If the cause of hematemesis cannot be found, aggressive inpatient investigations are required at the first sign of second bleed 4

References

Guideline

Management of Hematemesis and Melena

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Non-variceal Upper Gastrointestinal Bleeding and Its Endoscopic Management.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2024

Research

[Hematemesis. Extramural emergency].

Schweizerische medizinische Wochenschrift, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.